• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

13号染色体杂合性缺失与晚期前列腺癌相关。

Loss of heterozygosity on chromosome 13 is associated with advanced stage prostate cancer.

作者信息

Afonso A, Emmert-Buck M R, Duray P H, Bostwick D G, Linehan W M, Vocke C D

机构信息

Urologic Oncology Branch and Laboratory of Pathology, National Cancer Institute, Bethesda, Maryland 20892-1502, USA.

出版信息

J Urol. 1999 Sep;162(3 Pt 1):922-6. doi: 10.1097/00005392-199909010-00091.

DOI:10.1097/00005392-199909010-00091
PMID:10458409
Abstract

PURPOSE

In order to investigate the possible involvement of a tumor suppressor gene(s) on chromosome 13 in prostatic neoplasms, we performed loss of heterozygosity (LOH) analysis on normal and tumor pairs from 36 prostate cancer patients.

MATERIALS AND METHODS

Pure DNA was obtained from carcinoma cells and normal epithelium by tissue microdissection. The DNA had previously been analyzed for LOH on chromosomes 8 and 16. After an initial pilot experiment to determine the region(s) of significant LOH from 9 loci on chromosome 13q, 3 loci at and near the Rb1 locus (D13S153, D13S1319, and D13S1303) were chosen for further study.

RESULTS

The overall rate of LOH on chromosome 13 was 27.3%. Four tumors exhibited LOH at all 3 loci. Two tumors exhibited LOH at D13S153 but not at the other, more telomeric loci; two additional tumors had loss at D13S1303 or D13S1319 but not D13S153. These data suggest that a tumor suppressor gene involved in prostate cancer may be located just telomeric to Rb1. Analysis of clinical and pathological data from carcinomas with and without loss shows that chromosome 13q LOH is correlated with advanced stage prostate cancer.

CONCLUSIONS

Our LOH data suggests that there may be a tumor suppressor gene telomeric to Rb1 that is potentially involved in prostate cancer progression. Identification of this gene may be valuable in providing diagnostic and prognostic information for prostate cancer patients.

摘要

目的

为了研究13号染色体上一个或多个肿瘤抑制基因在前列腺肿瘤中的可能作用,我们对36例前列腺癌患者的正常组织与肿瘤组织配对样本进行了杂合性缺失(LOH)分析。

材料与方法

通过组织显微切割技术从癌细胞和正常上皮细胞中获取纯DNA。这些DNA之前已针对8号和16号染色体上的LOH进行过分析。在初步预实验确定13q染色体上9个位点的显著LOH区域后,选择Rb1位点及其附近的3个位点(D13S153、D13S1319和D13S1303)进行进一步研究。

结果

13号染色体上的总体LOH率为27.3%。4个肿瘤在所有3个位点均表现出LOH。2个肿瘤在D13S153位点表现出LOH,但在其他更靠近端粒的位点未出现;另外2个肿瘤在D13S1303或D13S1319位点出现缺失,但在D13S153位点未出现。这些数据表明,参与前列腺癌的一个肿瘤抑制基因可能位于Rb1基因的端粒侧。对有或无缺失的癌组织的临床和病理数据进行分析表明,13q染色体上的LOH与晚期前列腺癌相关。

结论

我们的LOH数据表明,可能存在一个位于Rb1基因端粒侧的肿瘤抑制基因,它可能参与前列腺癌的进展。鉴定该基因可能对为前列腺癌患者提供诊断和预后信息具有重要价值。

相似文献

1
Loss of heterozygosity on chromosome 13 is associated with advanced stage prostate cancer.13号染色体杂合性缺失与晚期前列腺癌相关。
J Urol. 1999 Sep;162(3 Pt 1):922-6. doi: 10.1097/00005392-199909010-00091.
2
Three distinct regions of allelic loss at 13q14, 13q21-22, and 13q33 in prostate cancer.前列腺癌中13q14、13q21 - 22和13q33处等位基因缺失的三个不同区域。
Genes Chromosomes Cancer. 1999 Jun;25(2):108-14.
3
Loss of heterozygosity at 13q14 and 13q21 in high grade, high stage prostate cancer.高级别、高分期前列腺癌中13号染色体长臂14区和21区杂合性缺失
Prostate. 2001 Nov 1;49(3):166-71. doi: 10.1002/pros.1131.
4
Limiting the location of a putative human prostate cancer tumor suppressor gene at chromosome 13q14.3.将一个假定的人类前列腺癌肿瘤抑制基因定位在染色体13q14.3上。
Oncogene. 1999 Dec 9;18(52):7576-83. doi: 10.1038/sj.onc.1203203.
5
Loss of heterozygosity at chromosome arm 13q and RB1 status in human prostate cancer.人类前列腺癌中13号染色体长臂杂合性缺失及RB1状态
Hum Pathol. 1999 Jul;30(7):809-15. doi: 10.1016/s0046-8177(99)90142-9.
6
Identification of a I-cM region of common deletion on 13q14 associated with human prostate cancer.鉴定与人类前列腺癌相关的13号染色体长臂14区常见缺失的1厘摩区域。
Genes Chromosomes Cancer. 1999 Mar;24(3):183-90.
7
Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer. Therapeutic implications.多种肿瘤抑制基因和12-脂氧合酶在人类前列腺癌中的作用。治疗意义。
Adv Exp Med Biol. 1997;407:41-53. doi: 10.1007/978-1-4899-1813-0_7.
8
Loss of heterozygosity and microsatellite instability at chromosomal sites 1Q and 10Q in morphologically distinct regions of late stage prostate lesions.晚期前列腺病变形态学不同区域中1号染色体和10号染色体位点的杂合性缺失及微卫星不稳定性
J Urol. 2001 Nov;166(5):1931-6.
9
An 800-kb region of deletion at 13q14 in human prostate and other carcinomas.人类前列腺癌及其他癌症中13q14处800千碱基的缺失区域。
Genomics. 2001 Oct;77(3):135-44. doi: 10.1006/geno.2001.6631.
10
High frequency of deletion on chromosome 9p21 may harbor several tumor-suppressor genes in human prostate cancer.
Int J Cancer. 1999 Nov 26;83(5):610-4. doi: 10.1002/(sici)1097-0215(19991126)83:5<610::aid-ijc7>3.0.co;2-2.

引用本文的文献

1
Significance of and Co-loss in Aggressive Prostate Cancer Progression.和在侵袭性前列腺癌进展中的共同缺失的意义。
Clin Cancer Res. 2020 Apr 15;26(8):2047-2064. doi: 10.1158/1078-0432.CCR-19-1570. Epub 2019 Dec 3.
2
Identification of a high frequency of chromosomal rearrangements in the centromeric regions of prostate cancer patients.前列腺癌患者着丝粒区域高频染色体重排的鉴定。
J Zhejiang Univ Sci B. 2007 Sep;8(9):638-46. doi: 10.1631/jzus.2007.B0638.